The efficacy and safety of propiverine hydrochloride in patients with overactive bladder symptoms who poorly responded to previous anticholinergic agents

Advances in Urology

Volumn , Issue , 2011, Pages

  Masumori, Naoya ^a   Miyamoto, Shintaro ^a   Tsukamoto, Taiji ^a   Furuya, Seiji ^b   Iwasawa, Akihiko ^c   Sato, Takashi ^d   Itoh, Naoki ^e   Shibuya, Akihiko ^f   Oda, Toshiro ^g  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Furuya Hospital   (Japan)

^c Iwasawa Clinic   (Japan)

^d Nisshin Urologic Clinic   (Japan)

^e Sapporo Medical Center   (Japan)

^f Kaguraoka Urological Clinic Urology Service   (Japan)

^g Kiyota Urological Clinic Urology Service   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052682446     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2011/714978     Document Type: Article

References (14)

1. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., Van Kerrebroeck P., Victor A., Wein A., The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society Neurourology and Urodynamics 2002 21 2 167 178 (Pubitemid 34195211)
2. Homma Y., Yamaguchi O., Hayashi K., An epidemiological survey of overactive bladder symptoms in Japan British Journal of Urology International 2005 96 9 1314 1318 (Pubitemid 41743931)
3. Yamaguchi O., Nishizawa O., Takeda M., Yokoyama O., Homma Y., Kakizaki H., Obara K., Gotoh M., Igawa Y., Seki N., Yoshida M., Clinical guidelines for overactive bladder International Journal of Urology 2009 16 2 126 142
4. Haruno A., Yamasaki Y., Miyoshi K., Effects of propiverine and its metabolites on isolated guinea pig urinary bladder Folia Pharmacol Japan 1989 94 145 150 (Pubitemid 19196055)
5. Stohrer M., Murtz G., Kramer G., Schnabel F., Arnold E. P., Wyndaele J. J., Propiverine compared to oxybutynin in neurogenic detrusor overactivity: results of a randomized, double-blind, multicenter clinical study European Urology 2007 51 1 235 242 (Pubitemid 44821506)
6. Homma Y., Yoshida M., Seki N., Yokoyama O., Kakizaki H., Gotoh M., Yamanishi T., Yamaguchi O., Takeda M., Nishizawa O., Symptom assessment tool for overactive bladder syndrome: overactive bladder symptom score Urology 2006 68 2 318 323 (Pubitemid 44175525)
7. Yamada A., Kobayashi Y., Aita T., Effect of propiverine on the atropine-resistant contraction of urinary bladders in aged rats Yamagata Medical Journal 2008 26 53 60
8. Anderson K. E., Pharmacology of lower urinary tract smooth muscles and penile erectile tissues Pharmacological Reviews 1993 45 3 253 308
9. Sugiyama Y., Yoshida M., Masunaga K., Satoji Y., Maeda Y., Nagata T., Inadome A., Ueda S., Pharmacological effects of propiverine and its active metabolite, M-1, on isolated human urinary bladder smooth muscle, and on bladder contraction in rats International Journal of Urology 2008 15 1 76 81
10. Itoh K., Nishi T., Post marketing surveillance of propiverine hydrochloride (BUP-4 tablets) in pollakiuria and urinary incontinence Japanese Pharmacology and Therapeutics 2002 30 12 1023 1036 (Pubitemid 36077422)
11. Tanaka Y., Masumori N., Clinical follow-up of patients treated with propiverine hydrochloride for pollakisuria and/or urinary incontinence Japanese Journal of Urological Surgery 2008 21 77 80
12. Chancellor M. B., Zinner N., Whitmore K., Kobashi K., Snyder J. A., Siami P., Karram M., Laramée C., Capo' J. P., Seifeldin R., Forero-Schwanhaeuser S., Nandy I., Efficacy of solifenacin in patients previously treated with tolterodine extended release 4mg: results of a 12-week, multicenter, open-label, flexible-dose study Clinical Therapeutics 2008 30 10 1766 1781
13. Swift S. E., Siami P., Forero-Schwanhaeuser S., Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4mg/day to solifenacin treatment: an open-label, flexible-dosing, multicentre study Clinical Drug Investigation 2009 29 5 305 316
14. Onishi T., Kato M., Hoshina A., The efficacy and safety for switchover treatment with second generation anti-muscarinic agent therapy in patients with overactive bladder J New Rem Clin 2010 59 374 380